Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-09 5:22 pm Unchanged | 13G | iBio Inc. IBIO | Opaleye Management Inc. | 650,000 7.63% | 0 (Unchanged) | View |
| 2024-04-08 8:18 pm Purchase | 13G | iBio Inc. IBIO | Opaleye Management Inc. | 650,000 7.63% | 650,000 (New Position) | View |
| 2024-02-14 7:48 pm Sale | 13G | OCULAR THERAPEUTIX INC OCUL | Opaleye Management Inc. | 6,070,000 5.51% | -5,000 (-0.08%) | View |
| 2024-02-14 4:05 pm Purchase | 13G | SANUWAVE Health Inc. SNWV | Opaleye Management Inc. | 115,493,554 9.09% | 84,064,983 (+267.48%) | View |
| 2024-02-09 4:05 pm Sale | 13G | Jounce Therapeutics Inc. JNCE | Opaleye Management Inc. | 0 0% | -2,810,000 (Position Closed) | View |
| 2024-02-09 4:05 pm Purchase | 13G | HARROW, INC. 8.625% SENIOR NOT HROWL | Opaleye Management Inc. | 3,820,000 10.88% | 45,000 (+1.19%) | View |
| 2024-02-09 4:05 pm Sale | 13D | Tracon Pharmaceuticals Inc. TCON | Opaleye Management Inc. | 0 0% | -2,518,371 (Position Closed) | View |
| 2024-02-09 4:05 pm Purchase | 13G | ETON PHARMACEUTICALS INC ETON | Opaleye Management Inc. | 2,524,887 9.84% | 354,887 (+16.35%) | View |
| 2024-01-05 4:05 pm Purchase | 13G | CONTEXT THERAPEUTICS INC CNTX | Opaleye Management Inc. | 820,000 5.14% | 820,000 (New Position) | View |
| 2023-04-12 4:15 pm Purchase | 13G | Jounce Therapeutics Inc. JNCE | Opaleye Management Inc. | 2,810,000 5.39% | 2,810,000 (New Position) | View |
| 2023-02-13 4:05 pm Sale | 13G | CHIMERIX INC CMRX | Opaleye Management Inc. | 0 0% | -5,580,000 (Position Closed) | View |
| 2023-02-13 4:05 pm Unchanged | 13G | SANUWAVE Health Inc. SNWV | Opaleye Management Inc. | 31,428,571 5.69% | 0 (Unchanged) | View |
| 2023-02-13 06:11 am Purchase | 13G | OCULAR THERAPEUTIX INC OCUL | Opaleye Management Inc. | 6,075,000 7.89% | 100,200 (+1.68%) | View |
| 2023-01-20 7:09 pm Purchase | 13G | LARIMAR THERAPEUTICS INC LRMR | Opaleye Management Inc. | 1,560,000 3.61% | 616,298 (+65.31%) | View |
| 2023-01-20 4:59 pm Purchase | 13G | HARROW, INC. 8.625% SENIOR NOT HROWL | Opaleye Management Inc. | 3,775,000 12.82% | 490,000 (+14.92%) | View |
| 2023-01-20 4:53 pm Sale | 13G | ETON PHARMACEUTICALS INC ETON | Opaleye Management Inc. | 2,170,000 8.58% | -215,000 (-9.01%) | View |
| 2022-06-10 4:05 pm Purchase | 13D | TELA BIO INC TELA | Opaleye Management Inc. | 1,557,500 10.69% | 806,332 (+107.34%) | View |
| 2022-06-03 4:05 pm Purchase | 13G | TELA BIO INC TELA | Opaleye Management Inc. | 751,168 5.16% | 751,168 (New Position) | View |
| 2022-02-18 4:32 pm Purchase | 13G | LARIMAR THERAPEUTICS INC LRMR | Opaleye Management Inc. | 943,702 5.32% | 943,702 (New Position) | View |
| 2022-01-31 9:02 pm Unchanged | 13G | Disc Medicine Inc. IRON | Opaleye Management Inc. | 0 0% | 0 (Unchanged) | View |